Drug Shortage Report for MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL

Last updated on 2018-12-19 History
Report ID 23172
Drug Identification Number 02443902
Brand name MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Common or Proper name EMTRICITABINE/TENOFOVIR DISOPROXIL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE
Strength(s) 300MG 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30BT
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-12-19
Actual start date
Estimated end date 2019-01-11
Actual end date 2018-12-18
Shortage status Avoided shortage
Updated date 2018-12-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v76 2018-10-09 French Compare
v75 2018-10-09 English Compare
v74 2018-09-24 French Compare
v73 2018-09-24 English Compare
v72 2018-09-17 French Compare
v71 2018-09-17 English Compare
v70 2018-09-10 French Compare
v69 2018-09-10 English Compare
v68 2018-08-21 French Compare
v67 2018-08-21 English Compare
v66 2018-06-25 French Compare
v65 2018-06-25 English Compare
v64 2018-06-05 French Compare
v63 2018-06-05 English Compare
v62 2018-05-08 English Compare
v61 2018-05-04 French Compare
v60 2018-05-04 English Compare
v59 2018-05-04 English Compare
v58 2018-05-03 French Compare
v57 2018-05-03 English Compare

Showing 21 to 40 of 96